OrthoPediatrics Corp. (KIDS)
NASDAQ: KIDS · Real-Time Price · USD
19.99
+0.15 (0.76%)
Jul 29, 2026, 4:00 PM EDT - Market closed
OrthoPediatrics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2.05 | 2.06 | 1.96 | 1.97 | 1.47 | 1.37 |
Short-Term Investments | 36.62 | 41.3 | 25.01 | 49.25 | 109.3 | 45.9 |
Cash & Short-Term Investments | 38.67 | 43.36 | 26.97 | 51.22 | 110.77 | 47.27 |
Cash Growth | 41.52% | 60.77% | -47.35% | -53.76% | 134.35% | -16.36% |
Accounts Receivable | 54.43 | 53.84 | 42.36 | 34.62 | 24.8 | 17.94 |
Total Trade Receivables | 54.43 | 53.84 | 42.36 | 34.62 | 24.8 | 17.94 |
Inventory | 134.02 | 133.79 | 117.01 | 105.85 | 78.19 | 57.57 |
Other Current Assets | 6.55 | 5.88 | 7.02 | 3.75 | 3.97 | 3.23 |
Total Current Assets | 245.87 | 256.42 | 237.17 | 226.5 | 226.72 | 133.65 |
Net Property, Plant & Equipment | 48.55 | 49.56 | 50.6 | 41.05 | 34.29 | 28.52 |
Other Intangible Assets | 76.72 | 77.71 | 81.18 | 84.56 | 79.9 | 69.76 |
Goodwill | 115.17 | 109.27 | 93.84 | 83.7 | 86.82 | 72.35 |
Other Long-Term Assets | 15.88 | 15.68 | 10.42 | 2.94 | - | - |
Total Assets | 502.19 | 508.63 | 473.21 | 438.75 | 427.73 | 304.27 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 19.7 | 18.79 | 8.91 | 12.65 | 11.15 | 9.33 |
Accrued Expenses | 12.77 | 13.69 | 13.89 | 11.33 | 6.74 | 5.35 |
Current Portion of Long-Term Debt | 0.17 | 0.17 | 0.16 | 0.15 | 0.14 | 0.14 |
Other Current Liabilities | 14.54 | 13.55 | 11.01 | 17.54 | 12.83 | 14.9 |
Total Current Liabilities | 47.18 | 46.2 | 33.96 | 41.67 | 30.87 | 29.72 |
Long-Term Debt | 100.39 | 99.82 | 72.96 | 9.91 | 0.76 | 0.91 |
Other Long-Term Liabilities | 15.91 | 16.02 | 11.73 | 10.15 | 17.45 | 48.28 |
Total Long-Term Liabilities | 116.3 | 115.84 | 84.68 | 20.05 | 18.21 | 49.19 |
Total Liabilities | 163.48 | 162.03 | 118.64 | 61.72 | 49.08 | 78.91 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-in Capital | 626.01 | 622.33 | 600.9 | 580.29 | 560.81 | 394.9 |
Accumulated Other Comprehensive Income | -1.4 | -0.52 | -10.77 | -5.53 | -5.4 | 8.49 |
Retained Earnings | -285.9 | -275.21 | -235.56 | -197.74 | -176.77 | -178.03 |
Shareholders' Equity | 338.71 | 346.6 | 354.57 | 377.03 | 378.65 | 225.37 |
Total Liabilities & Equity | 502.19 | 508.63 | 473.21 | 438.75 | 427.73 | 304.27 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 100.56 | 99.99 | 73.12 | 10.06 | 0.91 | 1.04 |
Net Cash (Debt) | -61.89 | -56.63 | -46.15 | 41.16 | 109.86 | 46.22 |
Net Cash Growth | - | - | - | -62.53% | 137.68% | -16.48% |
Net Cash Per Share | -2.63 | -2.41 | -2.00 | 1.81 | 5.25 | 2.40 |
Book Value | 338.71 | 346.6 | 354.57 | 377.03 | 378.65 | 225.37 |
Book Value Per Share | 14.37 | 14.77 | 15.36 | 16.63 | 18.08 | 11.70 |
Tangible Book Value | 146.82 | 159.62 | 179.54 | 208.76 | 211.93 | 83.26 |
Tangible Book Value Per Share | 6.23 | 6.80 | 7.78 | 9.21 | 10.12 | 4.32 |